Professional Documents
Culture Documents
(BSE: 538858)
Investor Presentation
March 2016
Cautionary Statement
This presentation contains statements that contain forward looking statements including, but
without limitation, statements relating to the implementation of strategic initiatives, and other
statements relating to Camson Bio Technologies Limiteds (Camson Bio Technologies) future
business developments and economic performance.
While these forward looking statements indicate our assessment and future expectations concerning
the development of our business, a number of risks, uncertainties and other unknown factors could
cause actual developments and results to differ materially from our expectations. These factors
include, but are not limited to, general market, macro-economic, governmental and regulatory trends,
movements in currency exchange and interest rates, competitive pressures, technological
developments, changes in the financial conditions of third parties dealing with us, legislative
developments, and other key factors that could affect our business and financial performance.
Camson Bio Technologies undertakes no obligation to publicly revise any forward looking statements
to reflect future / likely events or circumstances.
Contents
Company Overview
5 - 11
Industry Dynamics
13 - 15
Strategy: Path-to-Value
17 - 19
Business Operations
21 - 24
Financial Performance
26 - 27
Company Overview
Camson: At a Glance
Pioneer in zero residue biocide products, supported by scientific research spanning over two decades
Camson Bio Technologies Limited (Camson or the Company) is India's first integrated IPR driven
agricultural biotechnology company
Founded in 1993, Camson is headquartered in Bangalore, with primary focus on biotech R&D
Pioneer in zero residue farming products, which uses secondary metabolites (biological origin) of microbes
to kill / inhibit pathogens, with no use of chemicals
Recently filed patents for its discovery of Natural Fertilizer
Recognized by Deloitte as one the fastest growing technology companies in 2015 and conferred the
Technology Fast 500 award and awarded Leaders of Tomorrow Award by ET Now & Indiamart 2014-15
Product Type
Production
R&D
Long standing relationship with its institutional investors such as CLSA and SBI
22 Bio pesticides
7 Bio fertilizers
4 Water Soluble
Natural Fertilizers
Corporate History
Among Forbes Asias
best 200 companies
under a billion
Launched Zero
Residue line of farm
produce
Technology Fast 50
India 2010 award from
Deloitte
Best Green SME
award from Yes Bank
1993-2000
2008
1993: Started
operations
1995: IPO and went
public
2000: Launched
Calphomil, Camsons
first product based on
microbial extract
2010
2011
Operationalized new
R&D centre at
Doballapur; investment of
Rs. 300 mn
CLSA committed an
investment of US$ 10 mn
2012
2013
Organic certification by
USOCA, Dehradun
Most innovative
award at SIAL, Abu
Dhabi
Indira Gandhi
Excellence Award
2014 2015
Awarded
Leaders of
Tomorrow
award by ET
Now &
Indiamart
Filed patent for
Natural
fertilizers
6
Target Markets
Target Farmers
Headquartered in Bangalore,
has a 50 acre R&D centre
and production facility in
Dodaballapur, Bangalore
Retail
Product
Development
Officers
Product
consultancy &
Demos
Farmers
Highly Specialized
R&D Capabilities
Operational Excellence
Technologically advanced
manufacturing process
Developed an in-house
proprietary technology platform
consisting of 4,000+ microbes
database, screening technology
and a natural compound library
Well Established
Market Reach
Facilitate sales via two way
process: One of direct sales to the
retail shops and second is to
derive demand via product
demos and consultancy to the
farmers
Has a strong network of 2,600+
dealers, 300 distributors and
300+ marketing personnel spread
across India
Proprietary
Technology
Platform
(R&D)
Production
Facilities
Biocides
USP
Recognition
Camson biocides are target specific, bio degradable, high yielding and does not harm soil productivity
Longer shelf life and Pests/insects do not develop resistance to biocide even after multiple uses
Offer higher protection period
Zero-residue product
9
Santosh Nair
WTD & Chief Executive Officer
streamlining
processes
and
Board of Directors
A.N. Singh
Non-Executive Director
V.K. Singh
Non-Executive Director
Krishnaswamy Ramaswamy
B.C. Madappa
Reeta Gangwani
Gulshan K. Khanna
Key Developments
Received approval from Shareholders and Creditors for the Scheme of Arrangement (Demerger) of the Seeds Business to create a
separate entity Camson Seeds Limited ; record date of 22-Sep-2015; On 14-Nov-2015, Board of Camson Seeds approved
allotment of shares to all who are the shareholders of Camson Biotech as on the record date; Allotment done in Jan 2016
Appointed Deloitte Haskins & Sells as the statutory auditor of the Company
MOU with Zuari Agri Sciences to market Camson products through Zuaris distribution network
MOU with the Kerala Cardamom Processing & Marketing Company to facilitate residue free farming for Kerala farmers
MOU with Vazhakkulam Pineapple Growers & Processors to advance the usage of biocide products in pineapple farming
MOU with the Coconut Development Board (a Government of India enterprise), to undertake research on secondary metabolite
based biocides to control red palm weevil infesting coconut plantations
11
Industry Dynamics
12
Increasing
Food
Demand
7.2
5.7
1.75%
1.69%
Current
1.3
0.9
1994
2014
World
Agri
Ecological
Footprint
24%
1.7
2050E
Indian
50%
70%
Required growth
by 2050
Water Withdrawal
(100% = 3862 km3 H2O)
37%
70%
Reducing
Arable
Land
Current rate of
growth
0.38 ha
0.23 ha
0.15 ha
1970
2000
2050
Source: UN Population Report 2014, World Resource Institute Report on Global Food Challenges 2013, UN-FAO Agriculture Report
Asia, Latin Americas and South Africa are projected to have highest
demand for organic foods in the future
71
161.5
55
104.5
40
71.2
2008
2013
2018
47.2
7.3
73.8
9.6
2015
2018
2018
2012
2012
Biocides
market to
grow at a
CAGR of
4.7% from
2012-2018
13%
14%
17%
12%
Biocides Market
22%
18%
14
2012
2017
Approx. 18% of the crop yield worth US$ 19.6 bn is lost due
to pests every year in India
0.35
0.16
Cotton
2013
20%
Rice
Chilli
6% 6% 5%
Wheat
Vegetables
26%
Others
2018
Source: Tata Strategic Management Group, Care Report 2007, Dawn Magazine, SBI Cap, Technopak Organic Food Report 2012,
Camson Analysis
15
Strategy: Path-to-Value
16
Capitalizing on
our diverse
product range to
address the
farmer needs for
zero-residue
products, thereby
creating
sustainable
demand and
revenue stream
Pillars
of
Growth
Simplifying
Business Segments
Improving Support
Functions
Improved
business
agility
Liberating
resources to
re-invest in
R&D to fuel
further
growth
18
(Pre Demerger)
(Post Demerger)
Agri Biotech
(Biocides)
Agri Biotech
(Biocides)
Segment
Seeds Segment
Seeds
Cultivation
Seeds Trading
Demerger Highlights
Spin off
Seeds Segment
Cultivating Future
Growth
Most dynamics
like risk, capital
requirements &
return ratios of
both businesses
begun to differ,
necessitating need
for the demerger
Enhance focus on
the rapidly growing
Agri-biotech
business, to further
scale it up
Enhancing
Market Position
Building brand
equity
Further
penetrating the
Indian agri market
Business Operations
20
Sub Stages
Identifying target pathogen
Identification
Literature/data mining
Process Description
Isolation of microbes
Metabolite Research
Mass multiplication
Extraction of Sec Metabolites
Biocide testing
Production optimization
Product improvement
Field Trials
Formulations
Field trails
21
Biocides Business
Ability to leverage its first mover advantage in a market with significant growth potential
Agri Biotech
Products
(Biocides)
Bio Insecticides
Bio Fungicides
Bio Fertilizers
Bio Stimulants
22
Product Range
Agri Biotech (Biocides)
Bio Insecticides
Help protect crops
and produce high
quality yield
Has unique mode of
action, less toxic and
organic
Bio Fungicides
Bio Fertilizers
Bio Stimulants
Maximize farm
potential by
promoting plant
growth
Bio degradable
Improve productivity
Calgard
Calbahaar
Calobium
Calshri
Cal-mb
Calmonas
Calphorus
Calstim
Calhopp
Calderma
Calosphere
Caltika
Calmyte
Caltop
Calspiral
Camistrong
Calnova
Calphomil
Calzoto
Calhume
Calpaste
Calbase
Caltash
Calterm
23
Product Advantages
24
Financial Performance
25
Leverage Profile1
122.6
142.4
(61.5)
28.9
39.1
EBITDA Margin
nm
23.6%
27.4%
Depreciation &
Amortization
23.9
27.0
27.7
(85.0)
1.9
11.4
EBIT
(including other income)
EBIT Margin
(Rs. million)
Short Term Borrowings2
358.4
99.5
Total Debt
457.9
(11.0)
Net Debt
446.8
Net Worth
Total Debt / Net Worth (x)
nm
1.5%
8.0%
30.09.2015
Capital Employed
1,413.9
0.32x
1,871.8
Note:
1.
During the year, the Company has received order from the High Court for the demerger of the seeds business of the Company with an appointed
date of 1st April, 2014. Accordingly the above results have been presented for the Agri Biotech business. Consequently, the Company operates in
a single segment, i.e. Agri Biotech and the results relating to previous quarter/period/year are not comparable
2.
Short term borrowings include: a) Current portion of long-term maturities and b) Interest accrued but not due on borrowings & security deposit
26
Capital Structure
Shareholding Pattern (Dec. 31, 2015)
51.66%
24.47%
2.83%
Promoters
Key Investors
990
1,437
127.73 / 31.20
Bloomberg
CBTL:IN
Reuters
CAMS.BO
Sector
Biotechnology
21.04%
FIIs
DIIs
Others
Shareholding Pattern
Shareholders
Dec-15
Sep-15
Jun-15
Mar-15
Dec-14
Promoters
24.47%
24.46%
24.46%
24.46%
24.46%
21.04%
21.20%
21.30%
21.67%
21.32%
2.83%
2.85%
2.85%
2.84%
2.84%
Others
51.66%
51.49%
51.39%
51.03%
51.38%
29.99
29.99
29.99
29.99
29.99
27
Neethi
Camson Bio
Technologies
Saket Somani
Churchgate Partners
ir@camsonbiotechnologies.com
+91 80 4076 8906
camson@churchgatepartnersindia.com
+91 22 6169 5988